PAR 10.9% 24.5¢ paradigm biopharmaceuticals limited..

WANTED PARA-008 Trial Participants, page-65

  1. 4,093 Posts.
    lightbulb Created with Sketch. 6549
    Axel,
    Many thanks again for your wife’s account and experience and I too am sorry she didn’t get more (any) benefit.

    The analysis so far seems to suggest that it does indeed work best for patients that show some sign of BMLs and have experienced a large degree of traumatisation in terms of injury for example the professionals in the EAP program to date. Not withstanding that, there indeed have been cases where there are little BMLs involved and yet patients have experienced good pain relief and other symptomatic benefits.

    The perfect example are those that have been bone on bone and are still showing little or no BMLs

    Indeed a strong case for further research to determine what are best candidates but after all is said and done, we have a broad profile just within the OA landscape to tackle. This is truly encouraging.


    I hear the really invested ones are still buying today!
    Not advice


    ps: find myself at a lively little pub tonight off the beaten track, playing pool with the family! Haven’t done this for a little while!


    DYOR


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.030(10.9%)
Mkt cap ! $85.7M
Open High Low Value Volume
27.5¢ 27.5¢ 24.0¢ $429.9K 1.713M

Buyers (Bids)

No. Vol. Price($)
7 161991 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.5¢ 29634 2
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
Last
25.0¢
  Change
-0.030 ( 7.51 %)
Open High Low Volume
27.0¢ 27.0¢ 23.5¢ 433775
Last updated 15.57pm 03/05/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.